Individual Funding Requests (IFRs) reflect how the the CCGs make decisions about providing treatments to individuals that are not normally available through the NHS. We are currently in the process of refreshing this policy.
These policies are based on those previously used by NHS Leeds, the former primary care trust. They relate to how the CCGs make decisions about providing treatments that are not normally available through the NHS.
The CCGs in Leeds have agreed that they will have the same Individual Funding Requests policies to make sure that people in Leeds have the exactly the same access to the application process.
Like any other organisation, the NHS has limited resources and we have a duty to manage them carefully.
This means we have to:
- Look at evidence for the safety and effectiveness of any treatment
- Ensure that the services we pay for will give patients the greatest health gains from the resources we have.
- We have an over arching policy called the Individual Funding Request Process (IFRP), which is based on national best practice. This sets out the principles behind our decisions on individual treatments. It also explains the system we have for processing each request for treatment.
Individual Funding Requests Policy (Full Version) (426KB)
In order to view PDF documents you will need Adobe PDF ReaderIndividual Funding Requests (Core Principles) (175KB)
In order to view PDF documents you will need Adobe PDF ReaderIndividual Funding Requests (Patient Information) (310KB)
In order to view PDF documents you will need Adobe PDF ReaderDecisions on paying for treatments or drugs that are not normally funded are made by a panel. The panel is made up of a mix of clinically qualified people from hospital, general practice and public health, on clinical and independent members. The only change to the process as part of the update, is that a trained lay representative will now attend the panels to make sure that the proper process is followed and consistent decisions are made.
There are some treatments that are not routinely funded, for example, cosmetic surgery or treatment, complementary or alternative therapies, and some high-cost drugs. The policies relating to these, and some other treatments, must be refreshed on a regular basis. This is to ensure that they are kept up to date and in line with new technologies, clinical research, and changes in commissioning approaches.
Downloads:
Engagement Report(178KB)
In order to view PDF documents you will need Adobe PDF ReaderAlternative Therapy (Final Draft) (164KB)
In order to view PDF documents you will need Adobe PDF ReaderCosmetic Framework (Final Draft)
In order to view PDF documents you will need Adobe PDF ReaderEnd of Trial Treatment (Final Draft) (202KB)
In order to view PDF documents you will need Adobe PDF ReaderCommissioning Framework For Experimental Treatment (Final Draft) (240KB)
In order to view PDF documents you will need Adobe PDF ReaderInterventions Targeted (Final Draft) (478KB)
In order to view PDF documents you will need Adobe PDF ReaderNon NICE non Tariff Drugs Framework (Final Draft) (246KB)
In order to view PDF documents you will need Adobe PDF ReaderPrivate vs NHS (Final Draft) (150KB)
In order to view PDF documents you will need Adobe PDF ReaderUpright MRI (Final Draft) (174KB)
In order to view PDF documents you will need Adobe PDF ReaderIf you want to know what our policy is on a particular drug or treatment that is not listed above, you can contact:
NHS Leeds Clinical Commissioning Group
Suites 2- 4
Wira House
Wira Business Park
Leeds
LS16 6EB
Tel: 0113 8435223
E-mail: ifrpanel@nhs.net